Yubo International Biotech LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
Boao Biotech Ltd and its sole director, Yulin Cao, have jointly disclosed a beneficial ownership of 16.6% of Yubo International Biotech Ltd's Class A Common Stock.